Mereo BioPharma Group (MREO)
NASDAQ: MREO
· Real-Time Price · USD
1.74
0.03 (1.75%)
At close: Aug 15, 2025, 3:59 PM
1.74
0.00%
After-hours: Aug 15, 2025, 07:50 PM EDT
Mereo BioPharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -12.89M | -7.05M | -15M | -12.26M | -8.95M | -7.71M | -8M | -13.6M | -12.08M | -17.66M | -10.44M | -24.83M | -12.58M | 867.99K | 429.19K | 16.79M | 8.33M |
Depreciation & Amortization | 144K | 271.46K | -99.13K | 257K | 274.84K | 361.09K | 368.2K | 498.2K | 227K | 362.86K | 201.58K | 541.82K | 286.37K | 520.52K | 257.38K | 361.07K | 179.2K |
Stock-Based Compensation | 2.28M | 1.51M | 1.74M | 2.09M | 2.05M | 1.23M | 1.28M | 800.58K | 1.64M | 910.42K | 1.02M | 1.49M | 1.61M | 1.04M | 1.04M | 1.22M | 1.21M |
Other Working Capital | n/a | -933.73K | 910.07K | 1.18M | -1.16M | -165K | -165K | -1.04M | -441K | -445.8K | -1.48M | 1.77M | n/a | -132.47K | n/a | -1.58M | n/a |
Other Non-Cash Items | n/a | -5.02M | 6M | 588K | 3.09M | 644.03K | 673.21K | 12.03M | -70K | -2.92M | -3.05M | -1.4M | -1.88M | -24.15M | -12.66M | 3.56M | -1.74M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 8.77M | n/a | -8.77M | n/a | -1.09M | n/a | -1.88M | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 862.36K | -155.05K | 1.42M | -1.51M | 3.35M | 3.2M | -7.85M | 371K | -58.72K | -1.67M | 2.2M | 217.4K | 1.39M | 731.71K | -3.91M | -1.15M |
Operating Cash Flow | -8.33M | -9.42M | -7.52M | -7.9M | -7.99M | -2.12M | -2.47M | -16.73M | -9.25M | -20.62M | -13.93M | -24.15M | -12.35M | -20.89M | -10.2M | 13.75M | 6.82M |
Capital Expenditures | -20K | n/a | 699.22K | n/a | -699.6K | 415.58K | n/a | -415.58K | -419K | 1.22K | -929 | -12.96K | -6.57K | -729K | -360.46K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -300K | n/a | -699K | 1K | -700K | -292.93K | -289.43K | 83.18K | 80.81K | -98.89K | 451.77K | 1.05M | 646.3K | 153.98K | 76.14K | 691.63 | 689.25 |
Investing Cash Flow | -320K | -618.75 | 218.75 | 1K | -699.6K | -292.93K | -289.43K | -415.58K | -419K | -97.67K | 450.84K | 1.04M | 639.73K | -575.03K | -284.33K | 691.63 | 689.25 |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 422K | -40K | -594K | 46.78M | n/a | 4.57M | 4.55M | 67K | -565.02K | 275.91K | 262.69K | -177.72K | -191.79K | -240.71K | -239.86K | 108.33M | 53.77M |
Financial Cash Flow | 422K | -40K | -594K | 46.78M | n/a | 4.57M | 4.55M | -178.81K | -565.02K | -542.14K | 262.69K | -378.5K | -191.79K | -2.52M | -239.86K | 108.33M | 53.77M |
Net Cash Flow | -8.23M | -10.72M | -6.91M | 38.77M | -8.76M | 3.68M | 3.3M | -14.22M | -8.37M | -25.04M | -34.2M | -34.92M | -11.74M | -24.37M | -10.64M | 120.01M | 59.71M |
Free Cash Flow | -8.35M | -9.42M | -7.52M | -7.9M | -8.69M | -1.7M | -2.47M | -17.14M | -9.67M | -20.61M | -13.93M | -24.17M | -12.36M | -21.62M | -10.56M | 13.75M | 6.82M |